Larry H Bernstein | Search Results | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Search Results for 'Larry H Bernstein '

Podcast with Dr. Larry H. Bernstein, MD, FCAP, Interview by Gail S. Thornton, PhDc, Narrator’s Voice: Stephen J. Williams, PhD

Posted in on February 3, 2021|

Podcast with Dr. Larry H. Bernstein, MD, FCAP, Interview by Gail S. Thornton, PhDc, Narrator’s Voice: Stephen J. Williams, PhD Updated on 11/27/2020 From: “Dr. Larry Bernstein” <larry.bernstein@gmail.com> Reply-To: “Dr. Larry Bernstein” <larry.bernstein@gmail.com> Date: Friday, November 27, 2020 at 2:39 PM To: “Aviva Lev-Ari, PhD, RN” <AvivaLev-Ari@alum.berkeley.edu> Subject: Re: DID YOU AUDIT the Podcast Dr. […]

Read Full Post »

Medical Startups – Artificial Intelligence (AI) Startups in Healthcare

Posted in Academic Publishing, Advanced Computing Platform, Artificial Intelligence - General, Artificial Intelligence Applications in Health Care, Artificial Intelligence in CANCER, Artificial Intelligence in Health Care - Tools & Innovations, Big Data, BioIT: BioInformatics, BioIT: BioInformatics, NGS, Clinical & Translational, Pharmaceutical R&D Informatics, Clinical Genomics, Cancer Informatics, Machine Learning, Natural Language Processing (NLP) on March 2, 2022| 1 Comment »

Medical Startups – Artificial Intelligence (AI) Startups in Healthcare Reporters: Stephen J. Williams, PhD and Aviva Lev-Ari, PhD, RN and Shraga Rottem, MD, DSc, The motivation for this post is two fold: First, we are presenting an application of AI, NLP, DL to our own medical text in the Genomics space. Here we present […]

Read Full Post »

Happy 80th Birthday: Radioiodine (RAI) Theranostics: Collaboration between Physics and Medicine, the Utilization of Radionuclides to Diagnose and Treat: Radiation Dosimetry by Discoverer Dr. Saul Hertz, the early history of RAI in diagnosing and treating Thyroid diseases and Theranostics

Posted in Biomedical Measurement Science, Bone Disease and Musculoskeletal Disease, Bone marrow derived cells, Ca2+ triggered activation, Calcium, Calcium Signaling, Calmodulin Kinase and Contraction, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Screening, Clinical Diagnostics, Diagnostics and Lab Tests, Drug Carrier Design, Drug Delivery Platform Technology, Drug Toxicity, Endocrine Diseases, Medical Imaging Technology, Image Processing/Computing, MRI, CT, Nuclear Medicine, Ultra Sound, Prostate Cancer: Monitoring vs Treatment on March 2, 2021| Leave a Comment »

Happy 80th Birthday: Radioiodine (RAI) Theranostics: Collaboration between Physics and Medicine, the Utilization of Radionuclides to Diagnose and Treat: Radiation Dosimetry by Discoverer Dr. Saul Hertz, the early history of RAI in diagnosing and treating Thyroid diseases and Theranostics Guest Author: Barbara Hertz 203-661-0777 htziev@aol.com Celebrating eighty years of radionuclide therapy and the work […]

Read Full Post »

e-Voices Podcasting by LPBI: Celebrating Podcast #3 in an Audio Library on leading Scientists and Key Opinion Leaders in Biological Sciences

Posted in LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management on January 9, 2021| Leave a Comment »

e-Voices Podcasting by LPBI: Celebrating Podcast #3 in an Audio Library on leading Scientists and Key Opinion Leaders in Biological Sciences Authors: Aviva Lev-Ari, PhD, RN 2.0 LPBI had published today its third Podcast uploaded to our Cloud at WordPress.com https://pharmaceuticalintelligence.com/audio-podcasts/ Our three podcasts are about the careers of Leaders in Science and Medicine […]

Read Full Post »

Left Ventricular Volume Reduction and Reshaping as a Treatment Option for Heart Failure

Posted in Assist Devices: LV, Cardiomyopathy, congestive heart failure, Frontiers in Cardiology and Cardiovascular Disorders, Heart Failure (HF) on January 22, 2021| Leave a Comment »

Left Ventricular Volume Reduction and Reshaping as a Treatment Option for Heart Failure Reporter: Aviva Lev-Ari, PhD, RN Left Ventricular Remodeling and Its Reversal When the myocardium is subjected to abnormal mechanical and neurohormonal stresses, left ventricular remodeling ensues with a progression of structural, cellular, molecular, metabolic, and functional changes. In chronic heart failure […]

Read Full Post »

Series D, Volume Four: Human Reproductive System, Genomic Endocrinology and Cancer Types

Posted in on December 27, 2020|

Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases, Reproductive Genomic Endocrinology Volume Four: Human Reproductive System, Genomic Endocrinology and Cancer Types Series Content Consultant: Larry H. Bernstein, MD, FCAP, Emeritus CSO, LPBI Group http://www.amazon.com/dp/B08VTFWVKM Available on Amazon.com since 2/2/2021 Product details ASIN : B08VTFWVKM Publisher : Leaders in Pharmaceutical Business Intelligence (LPBI) Group; 1st edition […]

Read Full Post »

Dysregulation of ncRNAs in association with Neurodegenerative Disorders

Posted in Alzheimer's Disease, Biomarkers & Medical Diagnostics, Cerebrovascular and Neurodegenerative Diseases, Etiology, Molecular Genetics & Pharmaceutical, mRNA, mRNA Therapeutics, Neurodegenerative Diseases, Neurological Diseases, RNA Biology, RNA interference (RNAi) therapeutic, tagged Alzheimers Disease, neurodegenerative disorders, Neurological Disorders, Non-coding RNA, Parkinsons disease, RNA Biology, RNA interference (RNAi) therapeutic on January 11, 2021| Leave a Comment »

Dysregulation of ncRNAs in association with Neurodegenerative Disorders Curator: Amandeep Kaur Research over the years has added evidences to the hypothesis of “RNA world” which explains the evolution of DNA and protein from a simple RNA molecule. Our understanding of RNA biology has dramatically changed over the last 50 years and rendered the scientists with […]

Read Full Post »

@Amazon.com @pharma_BI BUNDLES for $274 #Patients #Voices #Precision #Medicine #Physiology #Genomics #Therapeutics #3D #BioPrinting: Series E: Volumes 1,2,3,4 by Editors: Larry H Bernstein @bernstein_h Gail Thornton @GailThornt Aviva Lev-Ari @AVIVA1950 ‏

Posted in 3D Printing for Medical Application, Genome Biology, Interviews with Scientific Leaders, Personalized and Precision Medicine & Genomic Research on January 20, 2019| Leave a Comment »

@Amazon.com @pharma_BI BUNDLES for $274 #Patients #Voices #Precision #Medicine #Physiology #Genomics #Therapeutics #3D #BioPrinting: Series E: Volumes 1,2,3,4 by Editors: Larry H Bernstein @bernstein_h Gail Thornton @GailThornt Aviva Lev-Ari @AVIVA1950 ‏ BioMed e-Series Series E: Patient-Centered Medicine – LINKS to e-Books & Cover Pages for Volumes 1,2,3,4 Volume 1: The VOICES of Patients, Hospitals CEOs, Health Care Providers, Caregivers and […]

Read Full Post »

Researchers develop novel therapy that could be effective in many cancers

Posted in Cancer - General, Cancer and Current Therapeutics, CANCER BIOLOGY & Innovations in Cancer Therapy, Genomic Expression, Loss of function gene, therapeutics, tagged Akt, Cancer - General, Clinical trial, Drug discovery, health, medicine, Mount Sinai, MS21, novel therapeutic approach, Novella Clinical, research, therapeutics on July 29, 2021| Leave a Comment »

Reporter: Danielle Smolyar, Research Assistant 3 – Text Analysis for 2.0 LPBI Group’s TNS #1 – 2020/2021 Academic Internship in Medical Text Analysis (MTA) Recently, researchers at Mount Sinai were able to develop a therapeutic agent that shows high levels of effectiveness in Vitro disrupting a biological pathway that allow cancer to survive. This finding […]